Literature DB >> 3516711

Presentation of alloantigens by host cells.

R A Sherwood, L Brent, L S Rayfield.   

Abstract

Presentation of alloantigens by host cells has been examined in vivo by means of a murine cell transfer system. Primary (1 degree) hosts were activated by the i.p. administration of allogeneic spleen cells and their spleen or peritoneal cells were transferred into syngeneic secondary (2 degrees) hosts 3 days later. Sensitization of 2 degrees hosts was assessed by their ability to reject donor strain skin grafts prematurely. The transferred cells were routinely depleted of T lymphocytes. We show that (a) 5 X 10(7) spleen and 3 X 10(6) peritoneal cells consistently caused marked accelerated graft rejection; (b) this effect was antigen specific and observable in all strain combinations studied; (c) it was caused by the active sensitization of 2 degrees hosts, but not by contaminating donor strain cells; (d) the cells involved were plastic adherent and viability was not a requirement; and (e) both class I and II, but not minor, histocompatibility antigens played a role in this model. We conclude that presentation of alloantigens by host antigen-presenting cells can be a potent route of allosensitization.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3516711     DOI: 10.1002/eji.1830160519

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

Review 1.  The role of graft-derived dendritic leukocytes in the rejection of vascularized organ allografts. Recent findings on the migration and function of dendritic leukocytes after transplantation.

Authors:  C P Larsen; J M Austyn; P J Morris
Journal:  Ann Surg       Date:  1990-09       Impact factor: 12.969

Review 2.  Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantation.

Authors:  Jenny Zilberberg; Rena Feinman; Robert Korngold
Journal:  Biol Blood Marrow Transplant       Date:  2014-11-20       Impact factor: 5.742

3.  Leucodepletion and Blood Products.

Authors:  Harsh Kumar; P K Gupta; D K Mishra; R S Sarkar; M Jaiprakash
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 4.  Heart transplantation: cellular and humoral immunity.

Authors:  M L Rose; M H Yacoub
Journal:  Springer Semin Immunopathol       Date:  1989

Review 5.  Lymphoid dendritic cells.

Authors:  J M Austyn
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

6.  Genetic and stimulator cell requirements for generation and activation of minor histocompatibility antigen-specific memory cytotoxic T-lymphocyte precursors.

Authors:  K I Ando; K I Isobe; T Hasegawa; T Iwamoto; R N Ding; J Rahman; Y Muro; T Yoshida; F Nagase; K Kawashima
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

7.  Alloreactive CD8 T cell tolerance requires recipient B cells, dendritic cells, and MHC class II.

Authors:  Thomas Fehr; Fabienne Haspot; Joshua Mollov; Meredith Chittenden; Timothy Hogan; Megan Sykes
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

8.  Bone marrow-derived chimerism in non-irradiated, cyclosporin-treated rats receiving microvascularized limb transplants: evidence for donor-derived dendritic cells in recipient lymphoid tissues.

Authors:  M Talmor; R M Steinman; M A Codner; M Chen; A D Harper; M D Witmer-Pack; L A Hoffman
Journal:  Immunology       Date:  1995-11       Impact factor: 7.397

9.  The effect of retinoids on dendritic cell function.

Authors:  P A Bedford; S C Knight
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

10.  Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides.

Authors:  J Fangmann; R Dalchau; J W Fabre
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.